NEW YORK (GenomeWeb News) – Dako today announced a project with Amgen to develop a companion diagnostic test using Dako's IQFISH hybridization buffer.

The buffer was introduced by Dako, an Agilent company, in 2012 and allows pathology laboratories to run DNA-based hybridization assays "with distinct and higher fluorescent signal intensity compared to traditional FISH assays," Dako said, adding IQFISH reduces diagnostic turnaround time to 3.5 hours from 17 hours.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.